Jon R. Levine - Apr 27, 2024 Form 4 Insider Report for MARIMED INC. (MRMD)

Role
President and CEO, Director
Signature
/s/ Jon R. Levine
Stock symbol
MRMD
Transactions as of
Apr 27, 2024
Transactions value $
-$12,773
Form type
4
Date filed
4/29/2024, 05:36 PM
Previous filing
Apr 3, 2024
Next filing
Sep 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRMD Common stock Options Exercise $0 +139K +0.69% $0.00 20.4M Apr 27, 2024 Direct F1
transaction MRMD Common stock Sale -$12.8K -50K -0.25% $0.26 20.3M Apr 29, 2024 Direct F2
holding MRMD Common stock 6.68M Apr 27, 2024 By the Jon Levine Family Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRMD Restricted Stock Units (RSU) Options Exercise $0 -139K -25% $0.00 417K Apr 27, 2024 Common Stock, par value $.001 per share 139K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 RSUs convert to shares of common stock on a one-for-one basis.
F2 Reflects shares of common stock sold pursuant to a Rule 10b5-1 instruction letter previously adopted by the Reporting Person on March 10, 2023 to satisfy tax withholding obligations in connection with the vesting of RSUs.
F3 These shares are held in trust for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4 The RSUs vest over a three-year period in equal one-sixth installments every six months following the October 27, 2022 grant date, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.